Why the study?
How can the risk of spinal bleeding be minimized in patients receiving central neuraxial blocks who have disturbed haemostasis?
How can the risk of spinal bleeding be minimized in patients receiving central neuraxial blocks who have disturbed haemostasis?
The SSAI provides consensus Nordic guidelines for the safe administration of central neuraxial blocks in patients with disturbed haemostasis to minimize spinal bleeding risks.
No takes yet. Share an insight, caveat, or question.
Implement Nordic guidelines to reduce spinal bleeding risk with neuraxial blocks; extends prior safety recommendations for patients with haemostatic disorders.
Breivik et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: